Risk of hypoglycemia in youth with type 2 diabetes on insulin.

Journal of Pediatric Endocrinology & Metabolism : JPEM
Madhia ShahidMicah Olson

Abstract

The objective of this study was to ascertain the risk of hypoglycemia among youth with type 2 diabetes (T2D) on insulin therapy. Twenty-two youth with T2D on insulin therapy (M=12, F=10, age=14.4±4.0 years) were enrolled from a single pediatric endocrine practice. They were followed-up for 3 months with weekly phone calls and monthly in-person visits to review blood glucose logs and document any signs or symptoms of hypoglycemia (defined as finger stick glucose of ≤70 mg/dL). Episodes of hypoglycemia were categorized into five categories: severe, documented symptomatic, asymptomatic, probable symptomatic and relative hypoglycemia. In addition to examining the risk of hypoglycemia, the degree to which hypoglycemia was associated with patient demographics (e.g. age, gender and body mass index [BMI]) or clinical factors (i.e. duration of diabetes, duration of insulin treatment, glycemic control or insulin dose and regimen) was determined. Nine hypoglycemic events occurred during the study period in five patients with an incidence rate of nine events per 5.3 patient-years. Of the hypoglycemic events, five were symptomatic and four were asymptomatic. No severe hypoglycemic events occurred. Hypoglycemia was not associated with age, e...Continue Reading

References

May 1, 1996·The Journal of Pediatrics·O Pinhas-HamielP Zeitler
Aug 23, 2000·The Journal of Clinical Investigation·B B Kahn, J S Flier
Apr 28, 2004·Diabetes Care·Edmond A RyanClarissa Wallace
Apr 28, 2005·Diabetes Care·UNKNOWN Workgroup on Hypoglycemia, American Diabetes Association
May 5, 2005·The Journal of Pediatrics·Orit Pinhas-Hamiel, Philip Zeitler
Jun 28, 2007·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the SEARCH for Diabetes in Youth Study GroupBeth Waitzfelder
Dec 1, 2007·Endocrine Reviews·Vincent Poitout, R Paul Robertson
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Oct 2, 2008·Journal of Pediatric Endocrinology & Metabolism : JPEM·Haiyan LuJose Bernardo Quintos
Oct 18, 2008·Journal of Pediatric Endocrinology & Metabolism : JPEM·E FelszeghyI Ilyes
Apr 21, 2009·Gastroenterology·Donghui LiJames L Abbruzzese
May 27, 2009·World Journal of Gastroenterology : WJG·Valter DonadonCesare Miranda
Jun 9, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Giuseppe Mancia, Guido Grassi
Jun 10, 2009·Clinics in Sports Medicine·Nathan Y WeltmanArthur Weltman
May 1, 2012·The New England Journal of Medicine·UNKNOWN TODAY Study GroupFrancine Kaufman
Jun 23, 2012·Diabetes Care·Lindsay B HarrisonIldiko Lingvay
Apr 2, 2013·Frontiers in Endocrinology·Marlon E Cerf
Jun 22, 2013·Diabetes Technology & Therapeutics·David R Owens
Feb 19, 2015·Pediatric Diabetes·Megan M KelseyUNKNOWN Treatment Options for Type 2 Diabetes in Adolescents and Youth Study Group
Apr 14, 2017·The New England Journal of Medicine·Elizabeth J Mayer-DavisUNKNOWN SEARCH for Diabetes in Youth Study

❮ Previous
Next ❯

Citations

Jun 4, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Hyder MirghaniRuba ALselaimy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.